BIOLIFE SOLUTIONS INC

For the period ended Dec 31, 2025. Filed Feb 26, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 26, 2026

BLFS$38.61+3.5%Stored close · as of Oct 5, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date:	February 26, 2026	BIOLIFE SOLUTIONS, INC.
		/s/ RODERICK DE GREEF
		Roderick de Greef
		Chief Executive Officer (principal executive officer) and Chairman of the Board of Directors

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Date:	February 26, 2026	/s/ RODERICK DE GREEF
		Roderick De Greef
		Chief Executive Officer (principal executive officer) and Chairman of the Board of Directors
Date:	February 26, 2026	/s/ TROY WICHTERMAN
		Troy Wichterman
		Chief Financial Officer (principal financial officer and principal accounting officer)
Date:	February 26, 2026	/s/ CATHERINE COSTE
		Catherine Coste
		Director
Date:	February 26, 2026	/s/ AMY DUROSS
		Amy DuRoss
		Director
Date:	February 26, 2026	/s/ RACHEL ELLINGSON
		Rachel Ellingson
		Director
Date:	February 26, 2026	/s/ JOYDEEP GOSWAMI
		Joydeep Goswami
		Director
Date:	February 26, 2026	/s/ TONY HUNT
		Tony Hunt
		Director
Date:	February 26, 2026	/s/ TIM MOORE
		Tim Moore
		Director

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.